BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22440914)

  • 1. Antivirals and resistance: influenza virus.
    Ison MG
    Curr Opin Virol; 2011 Dec; 1(6):563-73. PubMed ID: 22440914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivirals--current trends in fighting influenza.
    Król E; Rychłowska M; Szewczyk B
    Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
    Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing antiviral therapy for influenza: understanding the evidence.
    Ison MG
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral treatment of influenza in humans].
    Nüesch R
    Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza drug resistance.
    Pizzorno A; Abed Y; Boivin G
    Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of neuraminidase inhibitor susceptibility in influenza strains.
    Spanakis N; Pitiriga V; Gennimata V; Tsakris A
    Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1325-36. PubMed ID: 25301229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza antivirals and animal models.
    Caceres CJ; Seibert B; Cargnin Faccin F; Cardenas-Garcia S; Rajao DS; Perez DR
    FEBS Open Bio; 2022 Jun; 12(6):1142-1165. PubMed ID: 35451200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.